The worldwide market for Endometriosis is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2026, from X.X million US$ in 2019.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in

Major Region

s, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Astrazeneca
Valirx
Abbott
Abbvie Inc.
Pfizer, Inc.
Teva Pharmaceutical Industries ltd.
Astellas Pharma Inc.
Takeda Pharmaceutical Company Limited
Meditrina Pharmaceuticals
Allergan
Debiopharm Group
Evestra, Inc.
Addex Therapeutics
Neurocrine Biosciences, Inc.
Orphagen Pharmaceuticals, inc.
Elexopharm
Sanofi
Philogen
Ogeda S.A.
Repros Therapeutics Inc.
Kissei Pharmaceutical Co., ltd.
Bayer Ag
Myovant Sciences ltd.
Forendo Pharma
Obseva SA
Ipsen


Major Types Covered
Ultrasound
Pelvic exam
Laparoscopy
Magnetic Resonance Imaging (MRI)
Hysteroscopy
Sonohysterography

Major Applications Covered
Hospitals
Clinics
Research Institutes

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
…

Years considered for this report:

Historical Years:

2014-2018

Base Year:

2019

Estimated Year:

2019

Forecast Period:

2019-2026